Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Cosmos Health Inc.

Healthcare US COSM

0.1969USD
-0.0143(6.77%)

Last update at 2026-06-23T18:51:00Z

Day Range

0.190.20
LowHigh

52 Week Range

0.281.32
LowHigh

Fundamentals

  • Previous Close 0.21
  • Market Cap17.72M
  • Volume2328634
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-15.17976M
  • Revenue TTM65.27M
  • Revenue Per Share TTM2.15
  • Gross Profit TTM 7.90M
  • Diluted EPS TTM-0.57

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -19.14500M -16.18302M -18.54265M -13.05532M -7.84764M
Minority interest - - - - -
Net income -19.14500M -16.18302M -18.54265M -13.83037M -7.96165M
Selling general administrative 15.62M 11.73M 25.40M 12.61M 11.68M
Selling and marketing expenses 0.15M 0.35M - 0.63M 0.73M
Gross profit 7.90M 4.31M 4.35M 5.96M 8.33M
Reconciled depreciation 1.37M 1.25M 0.61M 0.19M 0.45M
Ebit -16.54082M -15.17070M - -7.47404M -4.53340M
Ebitda -15.17146M -13.92146M - -9.47345M -4.12628M
Depreciation and amortization 1.37M 1.25M - -1.99941M 0.41M
Non operating income net other - - - - -
Operating income -16.70360M -15.54483M -21.83122M -7.47404M -4.53340M
Other operating expenses 81.98M 69.97M - 57.82M 60.77M
Interest expense 2.62M 1.01M 0.87M 3.97M 3.58M
Tax provision 0.00000M 0.00000M 0.00000M 0.78M 0.11M
Interest income 0.40M 0.41M 0.66M 0.24M 0.05M
Net interest income -2.22622M -0.60586M -0.20362M -3.72890M -3.53455M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 6.20M - 0.78M 0.11M
Total revenue 65.27M 54.43M 53.38M 50.35M 56.24M
Total operating expenses 24.60M 19.86M 75.21M 13.43M 12.86M
Cost of revenue 57.38M 50.12M 49.03M 44.39M 47.91M
Total other income expense net -2.44139M -0.63819M 3.49M -5.58128M -3.31424M
Discontinued operations - - - - -
Net income from continuing ops -19.14500M -16.18302M -18.54265M -13.83037M -7.96165M
Net income applicable to common shares - - - - -15.59468M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 65.48M 54.31M 66.01M 68.04M 49.43M
Intangible assets 7.52M 7.71M 7.63M 0.66M 0.44M
Earning assets - - - - -
Other current assets 12.22M 4.89M 6.25M 5.43M 1.05M
Total liab 47.05M 29.78M 29.97M 28.38M 45.05M
Total stockholder equity 18.42M 24.53M 36.04M 39.66M 4.38M
Deferred long term liab - - - - -
Other current liab 18.85M 4.84M 3.47M 1.52M 1.30M
Common stock 0.04M 0.02M - 0.01M 0.02M
Capital stock 0.04M 0.02M 0.02M 0.38M 0.02M
Retained earnings -133.16727M -114.02227M -91.64423M -66.23281M -34.34551M
Other liab - - - - -
Good will 0.05M 0.05M 0.05M 0.05M 0.05M
Other assets - -0.00000M - - 6.01M
Cash 0.72M 0.32M 3.83M 20.75M 0.29M
Cash and equivalents - - - - -
Total current liabilities 38.27M 25.76M 24.32M 21.75M 29.93M
Current deferred revenue - - - - 2.94M
Net debt 10.08M 11.51M 7.43M -8.72466M 26.84M
Short term debt 4.79M 9.76M - 8.31M 13.56M
Short long term debt 13.52M 9.55M 8.23M 8.04M 13.34M
Short long term debt total 10.79M 11.82M - 12.03M 27.12M
Other stockholder equity 151.22M 140.67M - 106.64M 38.86M
Property plant equipment - - - - 1.88M
Total current assets 38.39M 25.46M 36.61M 56.04M 40.88M
Long term investments - - - - -
Net tangible assets - - - - 3.89M
Short term investments 0.05M 0.02M 0.02M 0.01M 0.00670M
Net receivables 19.63M 15.88M 19.76M 26.40M 30.14M
Long term debt 5.85M 1.56M 3.04M 2.86M 12.72M
Inventory 5.78M 4.36M 4.79M 3.45M 3.15M
Accounts payable 14.62M 11.16M 11.91M 11.92M 12.13M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.33M -2.13493M - -1.13264M -0.15162M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 8.34M 4.92M 1.06M 8.36M 0.92M
Deferred long term asset charges - - - - -
Non current assets total 27.09M 28.85M 29.41M 11.99M 8.55M
Capital lease obligations 0.60M 0.71M 1.16M 1.12M 1.06M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.79827M 0.00000M -0.02150M -0.82682M
Change to liabilities - - - - 3.82M
Total cashflows from investing activities -2.01485M -0.79827M - - -0.82682M
Net borrowings 10.47M 0.55M -0.02141M - 7.39M
Total cash from financing activities 14.06M 5.05M 12.69M 35.05M 7.27M
Change to operating activities - - - - -4.86405M
Net income -19.14500M -16.18302M -25.78383M -13.83037M -7.96165M
Change in cash 3.14M -3.51809M -16.91649M 20.46M -0.34191M
Begin period cash flow 0.32M 3.83M 20.75M 0.29M 0.63M
End period cash flow 3.46M 0.32M 3.83M 20.75M 0.29M
Total cash from operating activities -8.44761M -7.71703M -15.63600M -14.87064M -7.09717M
Issuance of capital stock 5.42M 0.65M 10.00M 41.28M 0.25M
Depreciation 1.37M 1.25M 0.61M 0.19M 0.45M
Other cashflows from investing activities -1.95918M -0.38019M - - 0.06M
Dividends paid - 6.20M - -32.00473M -7.63303M
Change to inventory -0.82998M 0.15M -0.89090M -0.48547M -0.08958M
Change to account receivables -6.10981M 1.23M -4.02637M -3.24418M -5.79257M
Sale purchase of stock - -0.10045M -0.10045M 0.00000M -0.37686M
Other cashflows from financing activities -1.83047M 10.04M - 72.17M 40.69M
Change to netincome - - - - 5.96M
Capital expenditures 0.06M 0.42M 9.17M 0.38M 0.89M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.77793M 0.16M -7.89874M -8.69276M -6.30003M
Stock based compensation 2.31M 1.69M 0.58M 0.02M 5.90M
Other non cash items 7.77M 5.38M -0.97575M 6.66M 1.52M
Free cash flow -8.50329M -8.13511M -24.80376M -15.25371M -7.98769M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COSM
Cosmos Health Inc.		 -0.0143 6.77% 0.20 - 4.79 0.27 1.06 0.59 -1.5985
COR
Cencora Inc.		 8.13 3.00% 279.41 37.46 17.70 0.19 31.84 0.20 17.10
MCK
McKesson Corporation		 18.77 2.52% 763.62 17.95 14.53 0.20 5.04 0.22 12.17
CAH
Cardinal Health Inc		 4.51 2.02% 227.25 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 1.54 1.96% 80.21 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

View All

Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Cosmos Health Inc.

141 West Jackson Boulevard, Chicago, IL, United States, 60604

Key Executives

Name Title Year Born
Mr. Grigorios Siokas Chairman & CEO 1965
Mr. Georgios Terzis Chief Financial Officer 1982
Mr. Pavlos Ignatiades Chief Operating Officer 1963
Mr. Demetrios G. Demetriades Sec. & Independent Director 1966
Mr. Demetrios G. Demetriades Secretary & Independent Director 1966
Mr. Nikolaos Bardakis Chief Operating Officer 1969
Mr. Georgios Terzis Chief Financial Officer 1983
Mr. Demetrios G. Demetriades Secretary & Independent Director 1965
Prof. Dimitrios Trafalis Head of Oncology NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.